News & Events

What Is Vagus Nerve Stimulation?

U.S. News & World Report turns to Spark Biomedical's Navid Khodaparast, PhD, to explain how vagus nerve stimulation works and what separates clinically validated devices from consumer wellness claims.

Spark Biomedical to Present Acute Stress Reaction, Anxiety, and Sleep Data at 2026 Military Health System Research Symposium

Company will present two scientific posters examining the operational and readiness applications of its tAN® platform, marking a key step in Spark's expansion into the military-ready and first responder space

Spark Biomedical to Present at 2026 NYC Neuromodulation Conference

Company will present groundbreaking tAN® research showing new data across stress resilience and hemorrhage control

Spark Biomedical and Feinstein Institutes Publish First-in-Human Study Demonstrating Non-Invasive tAN® Technology Enhances Platelet Function

Research published in Bioelectronic Medicine shows Spark's wearable auricular neurostimulation platform can enhance the body's natural clotting ability

Are electrical stimulation devices the way forward for addressing heavy menstrual bleeding in women with von Willebrand disease?

Commentary in Expert Review of Hematology by Maureen K. Baldwin, MD of Oregon Health & Science University, examining electrical stimulation devices for heavy menstrual bleeding in women with von Willebrand disease

Spark Biomedical Launches Pivotal Phase II LUNA Trial for Heavy Menstrual Bleeding

The LUNA Trial Marks a Major Clinical Milestone in Bioelectronic Medicine for Women’s Health

Spark Biomedical Announces Investment by Northwell Holdings to Advance Their OhmBody™ Transcutaneous Auricular Neurostimulation (tAN) for Menstruation

UT Southwestern and UTMB Awarded $500,000 TRC4 Grant to Study Non-Invasive Neurostimulation for Chronic Subdural Hematomas

Groundbreaking Trial to Use Spark Biomedical’s Sparrow Link™ Technology

Spark Biomedical Awarded an NIH Grant to Study the Treatment Effects of tAN® for Alcohol Withdrawal Symptoms

STTR Phase IAUD study to be conducted in partnership with Menninger Clinic and BaylorCollege of Medicine

Spark Biomedical Publishes First Peer-Reviewed Trial Showing Wearable Device Reduces Heavy Menstrual Bleeding

Pilot study demonstrates over 50% reduction in menstrual blood loss and improved symptoms using non-invasive, drug-free therapy